Physician profile
Michael E Metzger
NPI 1528042546
$2,441.80
in general payments reported to CMS, 2019-2025
22 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $84.55 · 2021: $489 · 2022: $389 · 2023: $238 · 2024: $181 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $389.60 | 2021-2025 | Epic, Mitraclip, Jot Dx |
| Medtronic Vascular, INC. | $340.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $340.17 | 2019-2023 | Xarelto |
| Elutia, INC. | $147.77 | 2021 | |
| Medtronic, INC. | $146.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $139.75 | 2019-2025 | Camzyos |
| Pfizer INC. | $133.64 | 2019 | |
| Atricure, INC. | $133.07 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $100.55 | 2025 | Wainua |
| Abiomed | $97.33 | 2022 | |
| Livanova USA, INC. | $92.90 | 2019 | |
| Intuitive Surgical, INC. | $88.68 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.44 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.80 | 2022-2024 | Lifevest |
| Inari Medical, INC. | $37.75 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.10 | 2021 | |
| Biotronik INC. | $17.00 | 2019 | |
| Cvrx, INC. | $16.36 | 2023 | Barostim Neo System |
| Ge Healthcare | $15.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.26 | 2019 | |
| Tactile Systems Technology INC | $13.39 | 2020 | |
| Amgen INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Metzger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.